221 results
8-K
VBIVQ
VBI Vaccines Inc
25 Jun 24
VBI Vaccines Announces Results of Annual General Meeting
4:15pm
meeting of shareholders and to authorize the audit committee (the “Audit Committee”) of the board of directors of the Company to fix EisnerAmper LLP’s … meeting of shareholders and to authorize the Audit Committee to fix EisnerAmper LLP’s remuneration
Votes For
Votes Against
Abstentions
Broker Non
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
25 Jun 24
VBI Vaccines Announces Results of Annual General Meeting
4:15pm
EisnerAmper LLP as VBI’s independent registered public accounting firm until the next annual meeting of shareholders and authorizing the audit committee
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(n) [RESERVED]
(o) Material
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
year may result in substantial penalties and result in the U.S. Holder’s taxable years being open to audit by the IRS until such forms are properly
8-K
EX-10.1
gl7htcyujbd
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm